User: MRM Proteomics (MRMP), Agilent, Bruker et Evosep
Contest: Canadian Biotechnology Innovation and Commercialization Initiative (CBIC)
SysQuan is a groundbreaking proteomics platform developed by researchers at McGill University and the University of Manitoba, in collaboration with MRM Proteomics (MRMP) and industry leaders such as Agilent, Bruker, and Evosep.
Unlike traditional methods, which are often complex and expensive, SysQuan enables the absolute quantification of thousands of proteins quickly, reliably, and at a fraction of the typical cost. The innovation lies in replacing costly synthetic labeled peptides with mouse tissues labeled at the whole-proteome level, reducing costs by a factor of 100 without sacrificing accuracy.
This technology allows large-scale analysis of biological samples and ensures consistent results across laboratories—a major challenge in biomedical research. SysQuan paves the way for faster advances in drug discovery, disease understanding, and the clinical application of proteomic data.
Beyond its scientific impact, SysQuan presents a strategic growth opportunity for MRMP. The project is expected to generate economic returns within the first five years, thanks in part to co-marketing agreements and rising demand in the biotech sector.
